WINDTREE THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
WINDTREE THERAPEUTICS INC. - More news...
WINDTREE THERAPEUTICS INC. - More news...
- Windtree Receives Notice of Delisting from NASDAQ
- Windtree Announces Successful Completion of Second and Final AEROSURF® Phase 2b Clinical Trial Interim Safety Review
- Windtree Therapeutics Reports Fourth Quarter 2016 Financial Results and Provides Key Business Updates
- Windtree Therapeutics' Aerosolized KL4 Surfactant Reduces Lung Inflammation and Improves Survival in a High-Pathogen Avian Influenza Preclinical Study
- Windtree Therapeutics Completes $10.5 Million Private Offering
- Windtree Therapeutics to Host a Conference Call and Webcast at 8:00 AM on Thursday, February 16, 2017 to Provide Clinical and Financial Updates
- Windtree Therapeutics Announces Upcoming Presentations at Hot Topics in Neonatology
- Windtree Therapeutics' AEROSURF® (lucinactant for inhalation) Phase 2a Data Presented at the 2016 International Congress of Union of European Neonatal and Perinatal Societies
- Windtree Therapeutics to Present at Stifel 2016 Healthcare Conference
- Windtree Therapeutics Preclinical Study Results Show Potential for KL4 Surfactant as Possible Medical Countermeasure to Radiation Exposure
- Windtree Releases Data from Lung Deposition Study in Non-Human Primates Demonstrating Uniform Distribution of Aerosolized KL4 Surfactant in all Regions of the Lung
- Windtree Therapeutics to Host Conference Call and Webcast on Tuesday, October 25, 2016 to Provide a Business Update
- Windtree Therapeutics Announces FDA Fast Track Designation for AEROSURF®
